Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-26

Clinical Trial Update: 24-months Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor [NA]

View source ↗

Summary

This update describes an ongoing clinical trial evaluating the safety and efficacy of Peroneal Transcutaneous NeuroModulation in Parkinson's disease and essenti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peroneal Transcutaneous NeuroModulation

Snippet

Sponsor: Stimvia s.r.o. | Conditions: Parkinson Disease, Essential Tremor | NA | Status: RECRUITING